News
Solid Biosciences' DMD gene therapy shows promise with SGT-003 and strong cash backing through 2027. Click here to read an ...
3d
Zacks.com on MSNUltragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
The draft is done. So is development camp. Free agency — never much of a frenzy to begin with — has mostly wrapped up, too.
TECH teams up with USP to boost mAb and gene therapy testing, aiming to simplify analytics and enhance product quality.
Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...
NHL free-agent market opened at noon ET on Tuesday. However, several teams avoided the rush by re-signing their pending ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $7.7, a high estimate of $11.00, ...
The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...
AHL Free Agency 2025 has officially begun. As all 32 teams look to fill out their rosters make sure you refresh this page daily for updates. Make sure you bookmark The Hockey News' AHL Page for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results